chr7-107683537-G-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000441.2(SLC26A4):c.1001G>T(p.Gly334Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,612,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000441.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A4 | NM_000441.2 | c.1001G>T | p.Gly334Val | missense_variant, splice_region_variant | 8/21 | ENST00000644269.2 | NP_000432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.1001G>T | p.Gly334Val | missense_variant, splice_region_variant | 8/21 | NM_000441.2 | ENSP00000494017.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250276Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135244
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460374Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726596
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74430
ClinVar
Submissions by phenotype
Pendred syndrome Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 09, 2021 | Variant summary: SLC26A4 c.1001G>T (p.Gly334Val) results in a non-conservative amino acid change located in the SLC26A/SulP transporter domain (IPR011547) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Three predict the variant weakens a 5' donor site, with two of them also predicting that it creates a new cryptic exonic 5 donor site. Experimental evidence supports these predictions demonstrating the variant affects mRNA splicing leading to inclusion of intronic material and introduction of a premature stop codon (e.g. Walsh_2006, Wasano_2020). The variant allele was found at a frequency of 8e-06 in 250276 control chromosomes (gnomAD). c.1001G>T has been reported in the literature to segregate with disease in families with multiple homozygous individuals affected with Pendred Syndrome (e.g. Walsh_2006, Kahrizi_2009). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact on protein function demonstrated the variant to impair ion transport activity (e.g. Dossena_2011, Wasano_2020). Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 16, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Oct 28, 2014 | - - |
Pathogenic, no assertion criteria provided | research | Hereditary Research Laboratory, Bethlehem University | Jun 04, 2016 | Severe to Profound SNHL - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:3Other:1
Pathogenic, criteria provided, single submitter | research | King Laboratory, University of Washington | Aug 01, 2020 | SLC26A4 c.1001G>T, p.G334V is a founder allele in the Palestinian population. Analysis of patient-derived RNA indicates that the variant disrupts the donor splice of SLC26A4 exon 8, with two mutant messages: (1) loss of exon 8 (83bp) with stop at codon 311. (2) activation of a cryptic splice donor with insertion of 40 bp in exon 8 message and stop at codon 355. (Abu Rayyan 2020). The variant is homozygous in 23 children from 10 Palestinian families with severe to profound pre-lingual hearing loss (Abu Rayyan 2020). It is absent from 1300 Palestinian controls and present in 51/250276 alleles on gnomAD, all heterozygotes. - |
Pathogenic, criteria provided, single submitter | clinical testing | The Shared Resource Centre "Genome", Research Centre for Medical Genetics | Nov 10, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 20, 2024 | - - |
Affects, no assertion criteria provided | in vitro;literature only | National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center | Aug 20, 2019 | in vitro experiment - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 334 of the SLC26A4 protein (p.Gly334Val). RNA analysis indicates that this missense change induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs146281367, gnomAD 0.003%). This missense change has been observed in individual(s) with SLC26A4-related conditions (PMID: 16460646, 18813951, 28964290). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 189039). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SLC26A4 function (PMID: 22116360). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this missense change results in the inclusion of part of intron 8 and introduces a premature termination codon (PMID: 16460646). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2024 | Demonstrated to create a cryptic splice site and result in loss-of-function (PMID: 16460646); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31599023, 29372807, 16460646, 31033086, 28964290, 18813951, 27771369, 32747562, 31589614, 22116360, 34426522, 36555390, 35982127, 39107234, Stepanova2022(article), 34632506, 33614372, 26445815, 38474007) - |
Hearing loss, autosomal recessive Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Pendred syndrome;C3538946:Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at